P-34 OUTCOME OF HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS AFTER UNIVERSAL ACCESS TO THERAPY
S. Blanco-Sampascual, I. Gorostiza-Hormaetxe, F. Menéndez-Blázquez, P. Ruiz-Eguiluz, A. Baranda-Martín, A. Castrillo-Olabarria, M.A. Gómez-Suárez, A. Calderón-García
Gastroenterology Department, Hospital Universitario Basurto, Bilbao, España
Read
826
Timeswas read the article
292
Total PDF
534
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 6 | 4 | 10 |
| 2025 11 | 26 | 23 | 49 |
| 2025 10 | 19 | 12 | 31 |
| 2025 9 | 9 | 9 | 18 |
| 2025 8 | 19 | 13 | 32 |
| 2025 7 | 20 | 10 | 30 |
| 2025 6 | 14 | 3 | 17 |
| 2025 5 | 14 | 3 | 17 |
| 2025 4 | 11 | 2 | 13 |
| 2025 3 | 20 | 3 | 23 |
| 2025 2 | 26 | 3 | 29 |
| 2025 1 | 42 | 7 | 49 |
| 2024 12 | 13 | 1 | 14 |
| 2024 11 | 24 | 3 | 27 |
| 2024 10 | 7 | 3 | 10 |
| 2024 9 | 9 | 2 | 11 |
| 2024 8 | 17 | 3 | 20 |
| 2024 7 | 7 | 6 | 13 |
| 2024 6 | 14 | 2 | 16 |
| 2024 5 | 13 | 7 | 20 |
| 2024 4 | 8 | 3 | 11 |
| 2024 3 | 7 | 4 | 11 |
| 2024 2 | 5 | 9 | 14 |
| 2024 1 | 10 | 5 | 15 |
| 2023 12 | 3 | 2 | 5 |
| 2023 11 | 10 | 4 | 14 |
| 2023 10 | 8 | 7 | 15 |
| 2023 9 | 7 | 6 | 13 |
| 2023 8 | 5 | 6 | 11 |
| 2023 7 | 5 | 2 | 7 |
| 2023 6 | 4 | 4 | 8 |
| 2023 5 | 3 | 1 | 4 |
| 2023 4 | 4 | 0 | 4 |
| 2023 3 | 1 | 2 | 3 |
| 2023 2 | 3 | 1 | 4 |
| 2023 1 | 1 | 3 | 4 |
| 2022 12 | 7 | 5 | 12 |
| 2022 11 | 7 | 8 | 15 |
| 2022 10 | 10 | 3 | 13 |
| 2022 9 | 6 | 8 | 14 |
| 2022 8 | 9 | 8 | 17 |
| 2022 7 | 12 | 7 | 19 |
| 2022 6 | 12 | 15 | 27 |
| 2022 5 | 6 | 10 | 16 |
| 2022 4 | 18 | 13 | 31 |
| 2022 3 | 15 | 12 | 27 |
| 2022 2 | 3 | 3 | 6 |
| 2022 1 | 5 | 6 | 11 |
| 2021 12 | 5 | 2 | 7 |
| 2021 11 | 2 | 4 | 6 |
| 2021 10 | 3 | 10 | 13 |
Show all
